Royal Bank of Canada’s VolitionRx Ltd VNRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q4 | – | Sell |
-330
| Closed | -$4K | – | 7678 |
|
|
2025
Q3 | $4K | Buy |
330
+180
| +120% | +$2.4K | ﹤0.01% | 6768 |
|
|
2025
Q2 | $2K | Buy |
+150
| New | +$1.65K | ﹤0.01% | 6824 |
|
|
2025
Q1 | – | Sell |
-1
| Closed | – | – | 7262 |
|
|
2024
Q4 | $0 | Buy |
+1
| New | +$13 | ﹤0.01% | 7285 |
|
|
2024
Q3 | – | Sell |
-4
| Closed | – | – | 7501 |
|
|
2024
Q2 | $0 | Buy |
4
+2
| +100% | +$29 | ﹤0.01% | 7578 |
|
|
2024
Q1 | $0 | Sell |
2
-21
| -91% | -$412 | ﹤0.01% | 7647 |
|
|
2023
Q4 | $0 | Buy |
+23
| New | +$338 | ﹤0.01% | 7627 |
|
|
2023
Q3 | – | Sell |
-20
| Closed | -$1K | – | 7646 |
|
|
2023
Q2 | $1K | Buy |
+20
| New | +$658 | ﹤0.01% | 7094 |
|
|
2022
Q4 | – | Sell |
-9
| Closed | – | – | 7765 |
|
|
2022
Q3 | $0 | Buy |
+9
| New | +$340 | ﹤0.01% | 7906 |
|
|
2022
Q2 | – | Sell |
-1
| Closed | – | – | 7747 |
|
|
2022
Q1 | $0 | Buy |
+1
| New | +$57 | ﹤0.01% | 8044 |
|
|
2021
Q4 | – | Sell |
-2
| Closed | -$137 | – | 7914 |
|
|
2021
Q3 | $0 | Sell |
2
-68
| -97% | -$4.31K | ﹤0.01% | 7896 |
|
|
2021
Q2 | $5K | Sell |
70
-115
| -62% | -$7.78K | ﹤0.01% | 7082 |
|
|
2021
Q1 | $14K | Buy |
185
+100
| +118% | +$8.58K | ﹤0.01% | 6648 |
|
|
2020
Q4 | $6K | Buy |
85
+82
| +2,733% | +$5.64K | ﹤0.01% | 6599 |
|
|
2020
Q3 | $0 | Sell |
3
-547
| -99% | -$37.2K | ﹤0.01% | 6954 |
|
|
2020
Q2 | $43K | Sell |
550
-150
| -21% | -$10.8K | ﹤0.01% | 5295 |
|
|
2020
Q1 | $44K | Hold |
700
| – | – | ﹤0.01% | 5218 |
|
|
2019
Q4 | $66K | Hold |
700
| – | – | ﹤0.01% | 5314 |
|
|
2019
Q3 | $79K | Hold |
700
| – | – | ﹤0.01% | 4929 |
|
|
2019
Q2 | $44K | Hold |
700
| – | – | ﹤0.01% | 5347 |
|
|
2019
Q1 | $46K | Hold |
700
| – | – | ﹤0.01% | 5210 |
|
|
2018
Q4 | $25K | Hold |
700
| – | – | ﹤0.01% | 5484 |
|
|
2018
Q3 | $36K | Hold |
700
| – | – | ﹤0.01% | 5395 |
|
|
2018
Q2 | $28K | Hold |
700
| – | – | ﹤0.01% | 5402 |
|
|
2018
Q1 | $34K | Hold |
700
| – | – | ﹤0.01% | 5234 |
|
|
2017
Q4 | $41K | Hold |
700
| – | – | ﹤0.01% | 5267 |
|
|
2017
Q3 | $37K | Hold |
700
| – | – | ﹤0.01% | 5597 |
|
|
2017
Q2 | $50K | Hold |
700
| – | – | ﹤0.01% | 5121 |
|
|
2017
Q1 | $56K | Hold |
700
| – | – | ﹤0.01% | 5088 |
|
|
2016
Q4 | $64K | Buy |
+700
| New | +$62.8K | ﹤0.01% | 5115 |
|
Other funds holding VNRX
LIM
SBCM
Royal Bank of Canada's VNRX Position: Q4 2025 in Review
Royal Bank of Canada sold out of VolitionRx Ltd (VNRX) in Q4 2025, closing a stake of 330 shares — an estimated $4K sold.
Royal Bank of Canada first reported a position in VNRX in Q4 2016 and held it in 29 quarters. The position peaked at $79K in Q3 2019. 28 funds tracked by Wall St. Rank hold VNRX as of Q4 2025.
- Royal Bank of Canada reported no remaining VolitionRx Ltd position as of Q4 2025 after selling out during the quarter.
- Royal Bank of Canada sold 330 VolitionRx Ltd shares in Q4 2025, an estimated $4K.
- Royal Bank of Canada first reported a position in VolitionRx Ltd in Q4 2016 and held it in 29 quarters.
- Royal Bank of Canada's VolitionRx Ltd position peaked at $79K in Q3 2019.
- 28 funds tracked by Wall St. Rank held VolitionRx Ltd as of Q4 2025.
Based on Royal Bank of Canada's 13F filing for Q4 2025, filed 17 Feb 2026.